Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and Src activity using an active component of Antrodia cinnamomea mycelia

Cancer initiating cells (CICs) represent a subpopulation of cancer cells, which are responsible for tumor growth and resistance to chemotherapy. Herein, we first used a cell-based aldehyde dehydrogenase (ALDH) activity assay to identify that YMGKI-2 (also named as Ergone), an active component purified from Antrodia cinnamomea Mycelia extract (ACME), effectively abrogated the ALDH activity and abolished the CICs in head and neck squamous cell carcinoma cells (HNSCCs). Consequently, YMGKI-2 treatment suppressed self-renewal ability and expression of stemness signature genes (Oct-4 and Nanog) of sphere cells with enriched CICs. Moreover, YMGKI-2 treated sphere cells displayed reduction of CICs properties and promotion of cell differentiation, but not significant cytotoxicity. YMGKI-2 treatment also attenuated the tumorigenicity of HNSCC cells in vivo. Mechanistically, treatment of YMGKI-2 resulted in inactivation of STAT3 and Src. Lastly, combinatorial treatments with YMGKI-2 and standard chemotherapeutic drugs (cisplatin or Fluorouracil) restored the chemosensivity on sphere cells and cisplatin-resistant HNSCC cells. Together, we demonstrate that YMGKI-2 treatment effectively induces differentiation and reduces tumorigenicity of CICs. Further, combined treatment of YMGKI-2 and conventional chemotherapy can overcome chemoresistance. These results suggest that YMGKI-2 treatment may be used to improve future clinical responses in head and neck cancer treatment through targeting CICs.

• Publication year

  2016

• Venue

  OncoTarget

• Publication date

  2016-09-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.18632/oncotarget.12194PMID 27682875PMCID 5341960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells

  2016cited by this paper
• Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells

  2015cited by this paper
• Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor

  2015cited by this paper
• Antrodia cinnamomea alleviates cisplatin-induced hepatotoxicity and enhances chemo-sensitivity of line-1 lung carcinoma xenografted in BALB/cByJ mice

  2015cited by this paper
• Ergosterol purified from medicinal mushroom Amauroderma rude inhibits cancer growth in vitro and in vivo by up-regulating multiple tumor suppressors

  2015cited by this paper
• Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma

  2015cited by this paper
• Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity.

  2014influential reference
• Inhibitory effects of Pleurotus tuber-regium mycelia and bioactive constituents on LPS-treated RAW 264.7 cells

  2014cited by this paper
• STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells

  2014cited by this paper
• [Research progress on pharmacology, pharmacokinetics and determination of ergosta-4,6,8 (14),22-tetraen-3-one].

  2014cited by this paper
• ALDH‐1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients

  2014cited by this paper
• Enhanced distribution and anti-tumor activity of ergosta-4,6,8(14),22-tetraen-3-one by polyethylene glycol liposomalization.

  2013cited by this paper
• Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: a review.

  2013cited by this paper
• High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer

  2013cited by this paper
• The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

  2013cited by this paper
• Lung cancer tumorigenicity and drug resistance are maintained through ALDHhiCD44hi tumor initiating cells

  2013cited by this paper
• Antrodia camphorata ameliorates high-fat-diet induced hepatic steatosis via improving lipid metabolism and antioxidative status

  2013cited by this paper
• Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death

  2013cited by this paper
• Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment.

  2012cited by this paper
• Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors.

  2012influential reference
• The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Curcumin promotes differentiation of glioma‐initiating cells by inducing autophagy

  2012cited by this paper
• Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm.

  2012cited by this paper
• Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells

  2012cited by this paper
• The cancer stem cell: premises, promises and challenges

  2011cited by this paper
• CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer

  2011cited by this paper
• Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.

  2011cited by this paper
• Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.

  2011cited by this paper
• Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds

  2011cited by this paper
• Antioxidant activities of extracts and metabolites isolated from the fungus Antrodia cinnamomea

  2011cited by this paper
• CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.

  2011cited by this paper
• Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.

  2011cited by this paper
• Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.

  2011cited by this paper
• Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform

  2011cited by this paper
• Ergosta‐4,6,8(14),22‐tetraen‐3‐one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid‐induced nephropathy rats

  2011cited by this paper
• A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation

  2011cited by this paper
• Cancer risks from betel quid chewing beyond oral cancer: a multiple-site carcinogen when acting with smoking

  2010cited by this paper
• Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma–Derived CD44+ALDH1+ Cells

  2010cited by this paper
• Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling

  2010cited by this paper
• Src signaling in cancer invasion

  2010cited by this paper
• Bioactivity-directed isolation, identification of diuretic compounds from Polyporus umbellatus.

  2009cited by this paper
• Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases.

  2009cited by this paper
• Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma

  2008cited by this paper
• Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells.

  2008cited by this paper
• Recent advances in head and neck cancer.

  2008cited by this paper
• Ergosta-4,6,8(14),22-tetraen-3-one from Vietnamese Xylaria sp. possessing inhibitory activity of nitric oxide production

  2008cited by this paper
• The Bcl-2 Family Protein Inhibitor, ABT-737, Has Substantial Antimyeloma Activity and Shows Synergistic Effect with Dexamethasone and Melphalan

  2007cited by this paper
• Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

  2007cited by this paper
• Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

  2006cited by this paper
• Cytotoxic Activity of Ergosta-4,6,8(14),22-tetraen-3-one from the Sclerotia of Polyporus umbellatus

  2005cited by this paper
• Establishment of high- and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS

  2005cited by this paper
• Antioxidant properties of methanolic extracts from two kinds of Antrodia camphorata mycelia

  2004cited by this paper
• Six immunosuppressive features from an ascomycete, Zopfiella longicaudata, found in a screening study monitored by immunomodulatory activity.

  2004cited by this paper
• Cell differentiation lineage in the prostate.

  2001cited by this paper
• Zhankuic acid F: a new metabolite from a formosan fungus Antrodia cinnamomea.

  1997influential reference
• Component Societies: active, life, retired members.

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• Involucrin and other markers of keratinocyte terminal differentiation.

  1983influential reference
• The occurrence of Ergosta-4,6,8(14),22-tetraen-3-one in several fungi

  1975cited by this paper

• Cancer stem cells of head and neck squamous cell carcinoma; distance towards clinical application; a systematic review of literature.

  2023cites this paper
• Antrodia cinnamomea Extract Attenuates Cisplatin-Induced Muscle Atrophy, Apoptosis, and Cell Growth Suppression

  2023cites this paper
• The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer

  2022cites this paper
• Structure and Biological Activity of Ergostane-Type Steroids from Fungi

  2022cites this paper
• Patient-Derived Tumor Chemosensitization of GKB202, an Antrodia Cinnamomea Mycelium-Derived Bioactive Compound

  2021cites this paper
• Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells

  2020cites this paper
• Blastemal NCAM+ALDH1+ Wilms' tumor cancer stem cells correlate with disease progression and poor clinical outcome: A pilot study.

  2019cites this paper
• Protective Effect of Antrodia cinnamomea Extract against Irradiation-Induced Acute Hepatitis

  2019cites this paper
• DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells

  2018cites this paper
• The roles of FOX proteins in virus‐associated cancers

  2018cites this paper
• Effects of Taiwanofungus camphoratus on non-specific and specific immune activities in mice

  2018cites this paper
• Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

  2017cites this paper
• Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression.

  2017cites this paper
• Antcin-H Isolated from Antrodia cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-β/c-Fos-MMP-7 Pathways

  2017cites this paper